Medicare Enrolled

Nino Alapishvili

Nephrology · Gurnee, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
1425 N HUNT CLUB RD STE 301, Gurnee, IL 60031
8478555215
Registered in NPPES since 2008
NPI: 1508033226 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Alapishvili from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Alapishvili? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Alapishvili

Nino Alapishvili is a nephrology specialist in Gurnee, IL, with 18 years of NPI registration. Based on federal Medicare data, Alapishvili performed 1,994 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Alapishvili received a total of $5,550 from 40 pharmaceutical and/or device companies across 208 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Alapishvili is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years of NPI registration ▲ Top 32% volume in IL $5,550 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,994
Medicare services
Top 32% in IL for nephrology
Not available
Unique patients (not deduplicated)
$120
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
969 $97 $213
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
273 $61 $273
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
201 $140 $419
Dialysis services for patients 20 or older
Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month.
190 $280 $648
Home dialysis services per month
Monthly dialysis treatment provided in the patient's home for individuals aged 20 or older.
90 $239 $540
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
86 $50 $128
Nursing facility visit, moderate complexity
A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes.
73 $79 $116
Dialysis services for adults, 2-3 visits per month
This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month.
46 $238 $540
Hemodialysis, single evaluation
A dialysis procedure to filter waste from the blood, performed with a physician's evaluation.
31 $57 $157
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
21 $65 $149
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
14 $54 $205
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,550
Total received (2018-2024)
Avg $793/year across 7 years
Top 14% in IL for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
208
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,416
2023
$1,216
2022
$739
2021
$348
2020
$192
2019
$1,319
2018
$320

Payments by company (2024)

Mallinckrodt Hospital Products Inc.
$185
Travere Therapeutics, Inc.
$179
Boehringer Ingelheim Pharmaceuticals, Inc.
$119
Recor Medical Inc
$109
Lilly USA, LLC
$106
Amgen Inc.
$101
AstraZeneca Pharmaceuticals LP
$95
Otsuka America Pharmaceutical, Inc.
$93
Novartis Pharmaceuticals Corporation
$74
Bayer Healthcare Pharmaceuticals Inc.
$59
Alexion Pharmaceuticals, Inc.
$58
Ardelyx, Inc.
$52
Fresenius USA Marketing, Inc.
$46
Aurinia Pharma U.S., Inc.
$26
Vifor Pharma, Inc.
$25
GlaxoSmithKline, LLC.
$24
Otsuka Pharmaceutical Development & Commercialization, Inc.
$24
Takeda Pharmaceuticals U.S.A., Inc.
$23
CALLIDITAS THERAPEUTICS US INC.
$19
Top 3 companies account for 34.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$825
Amgen Inc.
$460
Mallinckrodt Enterprises LLC
$451
Travere Therapeutics, Inc.
$403
Otsuka America Pharmaceutical, Inc.
$327
Mallinckrodt Hospital Products Inc.
$274
Boston Scientific Corporation
$268
ANI Pharmaceuticals, Inc.
$182
Bayer Healthcare Pharmaceuticals Inc.
$177
BARD PERIPHERAL VASCULAR, INC.
$143
Lilly USA, LLC
$138
Fresenius USA Marketing, Inc.
$137
OPKO Pharmaceuticals, LLC
$127
Boehringer Ingelheim Pharmaceuticals, Inc.
$119
Bayer HealthCare Pharmaceuticals Inc.
$115
Recor Medical Inc
$109
AKEBIA THERAPEUTICS INC
$100
Vifor Pharma, Inc.
$91
Takeda Pharmaceuticals U.S.A., Inc.
$90
Alexion Pharmaceuticals, Inc.
$82
Aurinia Pharma U.S., Inc.
$79
Novartis Pharmaceuticals Corporation
$74
Otsuka Pharmaceutical Development & Commercialization, Inc.
$73
Exeltis, USA Inc.
$72
NxStage Medical, Inc.
$70
Relypsa, Inc.
$57
GlaxoSmithKline, LLC.
$54
Mallinckrodt LLC
$53
Ardelyx, Inc.
$52
Horizon Therapeutics plc
$47
Daiichi Sankyo Inc.
$44
CALLIDITAS THERAPEUTICS US INC.
$43
Ultragenyx Pharmaceutical Inc.
$36
Horizon Pharma plc
$35
Keryx Biopharmaceuticals, Inc.
$35
Retrophin, Inc.
$31
Calliditas Therapeutics US Inc.
$24
Kyowa Kirin, Inc.
$23
Genentech USA, Inc.
$16
Shire North American Group Inc
$13
Top 3 companies account for 31.3% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ACTHAR · AURYXIA · Aranesp · Auryxia · BENLYSTA · CRYSVITA · Crysvita · FARXIGA · GATTEX · IBSRELA · INJECTAFER · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LOKELMA · LUPKYNIS · LUTONIX · PARADISE RENAL DENERVATION SYSTEM · PURIFIED CORTROPHIN GEL · Parsabiv · RAYALDEE · Rayaldee · Rituxan · SAMSCA · SYSTEM ONE · TARPEYO · TAVNEOS · TERLIVAZ · TRADJENTA · Tavneos · Thiola · ULTOMIRIS · Velphoro · Veltassa · WATCHMAN
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a nephrology specialist in Gurnee?
Compare nephrologists in the Gurnee area by procedure volume, costs, and industry payment transparency.
Browse nephrologists nearby

Geographic Context

Nephrologists in nearby ZIP areas
57
County median income
$108,917
Nearest hospital to ZIP centroid (approximate)
VISTA MEDICAL CENTER EAST
4.2 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Alapishvili is a clinical cardiology specialist, with moderate Medicare volume, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Alapishvili experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Alapishvili performed 969 hospital follow-up visit, high complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Alapishvili receive payments from pharmaceutical companies?
Yes. Alapishvili received a total of $5,550 from 40 companies across 208 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Alapishvili's costs compare to other nephrologists in Gurnee?
Alapishvili's average Medicare payment per service is $120. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Alapishvili) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →